atezolizumab,palbociclib
roche,pfizer
['impower 010', 'pearl', 'atezo']
#asco22 while pearls did meet its endpoint, we already have atezolizumab approved in this space after impower 010. notes differences between these trials and again - is chemo needed to maximize benefit (additive and synergistic?). 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him